Hikal lost 4.57% to Rs 488.95 at 10:25 IST on BSE after net profit declined 66.8% to Rs 3.07 crore on 20% growth in net sales to Rs 227.54 crore in Q4 March 2014 over Q4 March 2013.
The Q4 result was announced after market hours on Tuesday, 6 May 2014.
Meanwhile, the S&P BSE Sensex was down 21.83 points or 0.1% at 22,486.59.
On BSE, so far 3,251 shares were traded in the counter as against average daily volume of 5,764 shares in the past one quarter.
The stock hit a high of Rs 501.05 and a low of Rs 484.30 so far during the day. The stock had hit a 52-week low of Rs 380.30 on 26 July 2013. The stock had hit a 52-week high of Rs 556 on 27 January 2014.
The stock had outperformed the market over the past one month till 6 May 2014, surging 8.09% compared with the Sensex's 0.67% rise. The scrip had, however, underperformed the market in past one quarter, sliding 2.09% as against Sensex's 10.82% rise.
The small-cap company has equity capital of Rs 16.44 crore. Face value per share is Rs 10.
Hikal's net profit jumped 151.2% to Rs 64.08 crore on 25.6% growth in net sales to Rs 829.21 crore in the year ended 31 March 2014 (FY 2014) over the year ended 31 March 2013 (FY 2013).
On consolidated basis, Hikal's net profit jumped 153.1% to Rs 63.90 crore on 25.6% growth in net sales to Rs 829.21 crore in FY 2014 over FY 2013.
Hikal's board of directors at its meeting held on Tuesday, 6 May 2014, recommended dividend of Rs 4.50 per share for FY 2014, subject to the approval of shareholders in the ensuing Annual General Meeting.
Hikal provides active ingredients, intermediates, R&D services and solutions to companies in the pharmaceuticals, biotech, agrochemicals and specialty chemicals industries.
Powered by Capital Market - Live News
